Given alongside Keytruda, a standard cancer #immunotherapy drug, fewer of the patients relapsed and fewer of their cancers spread than for those on Keytruda alone. It's the first time an mRNA cancer vaccine has worked in a late-stage trial.

Given alongside Keytruda, a standard cancer #immunotherapy drug, fewer of the patients relapsed and fewer of their cancers spread than for those on Keytruda alone. It's the first time an mRNA cancer vaccine has worked in a late-stage trial.
Breakthrough: Engineered T-cell therapy targeting three tumor proteins shows early survival gains in children with diffuse intrinsic pontine glioma (DIPG) and rel… #Braincancer #Celltherapy #Clinicaltrial #DIPG #Immunotherapy #Braincancer #Celltherapy #Clinicaltrial #DIPG #Immunotherapy https:…
Centre National de la Recherche Scientifique is hiring:
Postdoctoral Researcher in Immunotherapy
What if the next generation of cancer therapies comes from understanding how proteins interact—not just looking at individual proteins?
Read the open-access paper in Nature: www.nature.com/articles/s41...
#CancerResearch #Biotechnology #DrugDiscovery #Oncology #Immunotherapy
#Keytruda is a type of #immunotherapy called an immune checkpoint inhibitor. It may be prescribed for some people with triple-negative breast cancer, as well as some metastatic or inoperable breast cancers with specific biomarkers, including MSI-H, dMMR, or TMB-H.
Read more: https://bit.ly/4ipejwL
🚀 Get the #Oncology buzz from #ASCOGI25!
Top themes: #Efficacy 16.2%, #ClinicalTrials 16.1%, #Data 15.9%. #CRCsm & #GIOnc dominate, with #ctDNA & #Immunotherapy hot topics. 📊🩺
Download our full report! http://dlvr.it/TVRwF2
@ASCO
#SocialListening #LucidQuest
September 12, 2026
👉 What if, to better fight a tumor, we first needed to… target the immune cells that protect it?
🙂 Another encouraging news from Groupe UIG.
Read: science.org/doi/10.1126/...
#CancerResearch #Immunotherapy #mRNA #Nanomedicine
🎨 New Post: Unlocking Cancer's Fortress: How Sugar Shields Pave the Way for Immune Cell Assault
#ai #cancer #immunotherapy #TechNews #GlobalMedia
👇 View Full Illustration:
https://nextlogic-ai.achlabo.com/en/unlocking-cancers-fortress-how-sugar-shields-pave-the-way-for-immune-cell-assault/
A review on toxicities of T-cell engager-based therapies in solid tumors
@tamedoncol.bsky.social
@journals.sagepub.com
September 11, 2026
👉 What if pancreatic cancer used… the blood-clotting system to protect itself from the immune system?
🙂 Another encouraging news from Groupe UIG.
Read: www.mountsinai.org/about/newsro...
#Cancer #PancreaticCancer #Immunotherapy #ImmunoOncology #Oncology #CancerResearch
11 septembre 2026
👉 Et si le cancer du pancréas utilisait… le système de coagulation pour se protéger du système immunitaire?
🙂 Une autre nouvelle encourageante du Groupe UIG.
Lire: www.mountsinai.org/about/newsro...
#Cancer #PancreaticCancer #Immunotherapy #ImmunoOncology #Oncology
Exciting talks and inspiring insights await you 🧬🔬 We look forward to welcoming our speakers 😊
@efis-immunology.bsky.social @iuis-online.bsky.social @dgfi-yi.bsky.social @labminguet.bsky.social
@msubklewe.bsky.social @fau.de
#immunology26 #Immunotherapy #Immunoengineering
Tumor-infiltrating B cells could reshape #Cancer #Immunotherapy.
This review explores their diverse subtypes, tertiary lymphoid structures, signaling and crosstalk, and emerging B-cell checkpoints and #TherapeuticTargets.
#cancer #cancer vaccine #immunotherapy
🌐 www.newsmart.ch
Complete regression of #hepatoblastoma, the most common pediatric #liverCancer, in a 3-year-old treated with a novel #immunotherapy. A.Heckzey, D. Steffin et al @bcmhouston.bsky.social @nejm.org www.bcm.edu/news/care-st...
🧪 How the hunt for human #retroviruses led to the discovery of interleukin-2 and a path to #immunotherapy
#HTLV-1 Science www.science.org/doi/10.1126/...
D. Ni, G. Pinget, B. Santner-Nanan, et al., “ #Biomarkers Predicting Sustained Unresponsiveness After Oral #Immunotherapy in the OPIA Trial,”
👉 doi.org/10.1111/all.70478
#Allergy_journal
Watch more videos👉 journalallergy.com and youtube.com/@Allergy-TV
Molecular Medicine - Journal
Article in Press: Clinical transcriptomics towards a companion diagnostic framework for immunotherapy in cutaneous melanoma | #MolecularMedicine #Immunotherapy #Melanoma #Transcriptomics link.springer.com/article/10.1...
CAR-T therapy is an example of a "living medicine". How do engineered immune cells recognize and destroy cancer cells, and what challenges remain before these therapies become more widely accessible?
Read more: ctgct.si/en/objave/li...
Why is #CD44v6 exciting in AML?
#Decitabine treatment increases CD44v6 expression on DNMT3A-mutant AML cells, improving recognition & targeting by #CARTcells. A promising step toward precision #Immunotherapy. #medsky
Read: doi.org/10.1007/s115...
#currentmedicalscience #Oncology